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Abstract
Hypoadrenocorticism arises from 
insufficient adrenal gland function and is also 
known as Addison’s disease, a rarely occurring 
disease (0.1%) in dogs. Due to its oscillatory 
course and overall nonspecific symptoms, it 
is a diagnostic challenge for clinicians, and 
is often misdiagnosed or unattended among 
other differentials. There are two forms of 
hypoadrenocorticism: primary and secondary. 
The aim of this study was to analyse the data 
of dogs suffering from Addison’s disease, 
treated at the Clinic for Internal Medicine, 
Faculty of Veterinary Medicine, University 
of Zagreb, Croatia and to compare them with 
data from similar institutions worldwide. 
The archive of Clinic for Internal Medicine, 
Faculty of Veterinary Medicine, Zagreb, 
Croatia was searched to investigate and 
statistically analyse signalment, clinical 
and laboratory data, and the duration of 
symptoms, treatment protocols and outcome 
of canine hypoadrenocorticism. The study 
group included 14 dogs (36% male and 64% 
female) diagnosed with hypoadrenocorticism. 
All dogs had a history of gastrointestinal 
symptoms, i.e. vomiting in 100%, diarrhoea 
in 64% and melena in 7%. Hypovolemic 
shock was noted in 57%, hypothermia in 64% 
and bradycardia in 29% of cases. The most 
frequently observed laboratory abnormalities 
were an increase in BUN (86%), creatinine 
(57%) and potassium concentration (79%), and 
a decrease in sodium (71%), Na/K ratio (86%), 
cholesterol (21%) and glucose concentration 
(21%). Duration of symptoms (till ACTH-
stimulation test performance) was broad, from 
2 – 2190 days (median 90±1195.5 days). The 
outcome was favourable in 100% cases after 
initiation of adequate treatment.
Key words: Addison’s disease; adrenal 
gland; mineralocorticoid deficiency; glucocorticoid 
deficiency; dog 
Introduction
Canine hypoadrenocorticism is a rare 
disease (with prevalence around 0.1%) 
characterised by hypofunction of the 
adrenal cortex. Since first being described 
by Thomas Addison in 1917, it has also 
been known as Addison’s disease. Due 
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to the non-specificity of clinical signs 
and their waxing and waning nature, 
hypoadrenocorticism is among the 
most underdiagnosed (if not the most 
underdiagnosed) diseases in veterinary 
medicine.
Regarding the pathophysiological 
mechanism, there are two main forms 
of hypoadrenocorticism: primary 
(lack of glucocorticoids and/or 
mineralocorticoids due to adrenal cortex 
destruction) and secondary (lack of 
adrenocorticotropic hormone (ACTH) 
due to abnormalities in the hypothalamic-
pituitary axis). Furthermore, primary 
hypoadrenocorticism can manifest as 
typical (lack of both mineralocorticoids 
and glucocorticoids, thus resulting in 
disturbances of Na and K concentrations 
and lowering of their ratio) or atypical 
(lack of glucocorticoids, characterized 
with normal Na and K concentration 
and their ratio) (Hess, 2017). Usually, 
at the time of presentation, the adrenal 
cortex, including the zona glomerulosa 
(mineralocorticoid production) and 
zonae fasciculata and reticularis (cortisol 
production) are destroyed at similar 
rates, resulting in a lack of both cortisol 
and aldosterone, thus causing primary 
typical hypoadrenocorticism (in 90–95% 
of cases) (Scott-Moncrieff, 2010; Scott 
Moncrieff, 2015; Klein and Peterson, 
2010a). However, the atypical form 
can convert into the typical form in 
due course, when the destruction of 
the zona glomerulosa catches up with 
the destruction of the zonae fasciculata. 
The aetiology may include immune-
mediated destruction of the adrenal 
cortex, drug-induced adrenocortical 
necrosis (mitotane), enzyme inhibition 
(trilostane) or infiltrative processes 
such as neoplastic or fungal disease 
(Klein and Peterson, 2010a). Central 
(anterior pituitary) deficiency of ACTH 
causes secondary hypoadrenocorticism 
(in 5–10% cases), resulting in isolated 
glucocorticoid insufficiency in which 
mineralocorticoids are spared as ACTH 
does not directly influence their release 
(Peterson et al., 1996). 
Hypoadrenocorticism is a disease 
of dogs of all ages (reported in animals 
from 4 months to 14 years old) and 
afflicts more female than male dogs 
(64% and 69% of reported cases being 
females) (Peterson et al., 1996; Adler et 
al., 2007; Seth et al., 2011; Hanson et al., 
2016). There are several overrepresented 
breeds and inheritance has been proven 
in some breeds (e.g. Standard Poodles, 
Nova Scotia Duck Tolling Retrievers, 
Portuguese Water Dogs and Bearded 
Collies) (Oberbauer et al., 2002; Famula 
et al., 2003; Hughes et al., 2007; Treeful 
et al., 2019). Other breeds commonly 
afflicted with hypoadrenocorticism 
where inheritance has not been proven 
are mixed breed dogs, Poodles (other 
than Standard Poodles), Golden 
Retrievers, Cairn Terriers, Rottweilers, 
Great Danes and West Highland White 
Terriers (Lathan and Thompson, 2018).
Due to the multisystemic effects of both 
glucocorticoids and mineralocorticoids, 
clinical signs are non-specific and can 
include signs that can be attributed 
to almost all body systems with poor 
appetite/anorexia (88% to 95%), lethargy/
depression (85% to 95%), vomiting/
regurgitation (68% to 75%), weakness 
(51% to 75%), weight loss (40% to 50%), 
diarrhoea (35%), polyuria/polydipsia 
(17% to 25%), shaking/shivering/tremors 
(17% to 27%), collapse (10%), and/or a 
painful abdomen (8%) as most commonly 
reported (Scott-Moncrieff, 2010). Since 
hypoadrenocorticism can mimic a large 
number of other diseases (i.e. kidney 
failure, inflammatory bowel disease) it has 
been nicknamed “the great pretender”. 
Clinical examination findings may range 
from a mildly dehydrated but alert dog, 
to a “shocked” and recumbent dog with 
a prolonged capillary refill time. Shock, 
bradycardia and atrial standstill with tall 
pointed T-waves in electrocardiogram 
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are common in critically ill patients in 
Addisonian crisis (Scott-Moncrieff, 2015).
Patients with hypoadrenocorticism 
may present with a myriad of laboratory 
abnormalities related to glucocorticoid 
and/or mineralocorticoid insufficiency, 
such as non-regenerative anaemia, 
leukocytosis, hypoglycaemia, elevated 
blood urea nitrogen (BUN) and 
creatinine, hyperkalemia, hyponatremia, 
hypercalcemia, hypocholesterolaemia, 
hyperphosphatemia, hypochloraemia, 
and elevated liver enzymes (Peterson et 
al., 1996).
The gold standard for diagnosing 
hypoadrenocorticism is the ACTH 
stimulation test that assesses the ability 
of adrenal gland to produce cortisol in 
response to a maximal stimulus (Scott-
Moncrieff, 2015; Botsford et al., 2018).
Since Addisonian crisis represents 
a real medical emergency, treatment 
is directed towards correcting 
hypovolemia, hypotension, electrolyte 
imbalances and providing corticosteroid 
and mineralocorticoid supplementation. 
Long-term management of stabilized 
hypoadrenocorticism is based on 
supplementation of corticosteroids and/or 
mineralocorticoids (desoxycorticosterone 
pivalate or fludrocortisone) (Scott-
Moncrieff, 2015; Jaffey et al., 2017). 
The routine monitoring of patients 
with hypoadrenocorticism is regular 
control via ACTH stimulation testing, 
although some authors recommend the 
measurement of endogenous ACTH as 
the best means of treatment surveillance 
(Zeugswetter and Haninger, 2018). 
Prognosis of canine hypoadrenocorticism 
is excellent with regular treatment. 
The aim of this study was to analyse 
the data collected from dogs with 
hypoadrenocorticism admitted to the 
Clinic for Internal Medicine, Faculty 
of Veterinary Medicine, University 
of Zagreb, Croatia, and to compare 
them with the data collected in similar 
institutions worldwide.
Materials and methods
No ethical approval was required as 
this study did not involve laboratory an-
imals, as only patient archive data from 
the system “Vef. Protokol 1.1.1.28” were 
used with signed owner’s consent. Among 
22,979 canine records (first admission 
data) at the Clinic for Internal Medicine, 
Faculty of Veterinary Medicine, Univer-
sity of Zagreb, Croatia in the period be-
tween November 2005 and August 2018, 
14 dogs were diagnosed with hypoadren-
ocorticism. The inclusion criterion was 
owner-signed informed consent for diag-
nostic and treatment procedures.
The following data were investigated 
and statistically analysed: breed, gen-
der, age, body weight, duration of clini-
cal signs until the time of diagnosis (by 
performing the ACTH-stimulation test), 
as well as the time frame between the on-
set of clinical signs and establishing the 
provisional diagnosis of hypoadrenocor-
ticism (based on history, clinical signs, 
clinical examination findings, standard 
laboratory workup and diagnostic imag-
ing). Furthermore, complete blood count 
(CBC), biochemistry, urinalysis, and diag-
nostic imaging were performed for each 
patient. Haematology was performed us-
ing Horriba ABX Haematology Analys-
er Diagnostics, Montpellier, France and 
biochemistry using the Olympus Diag-
nostica GMBH, Hamburg, Germany. 
The following biochemical parameters 
were analysed: BUN-blood urea nitro-
gen, (mmol/L), Cre-creatinine (µmol/L), 
ALT-alanine aminotransferase (U/L), 
AST-aspartate aminotransferase (U/L), 
AP-alkaline phosphatase (U/L), Chol-cho-
lesterol (mmol/L), CRP-canine-C-reactive 
protein (mg/L), TP-total proteins (g/L), 
Alb-albumins (g/L), BG- blood glucose 
(mmol/L), Ca-calcium (mmol/L), Na-so-
dium (mmol/L), K-potassium (mmol/L) 
and Na/K ratio. Patients with elevated 
concentrations of BUN (with or without 
elevated creatinine concentration) were 
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classified as azotaemic, either pre-renal 
(urine specific gravity>1030) or renal 
(urine specific gravity<1030).
Radiographic imaging was performed 
using Eichermeyer EDR HP (IMD 
Generators s.r.l., Italy) with digital 
data processing and image distribution 
with Agfa CR 30-X (Agfa, Japan), 
while ultrasound was performed using 
MyLabTM 40 (Esaote, Italy). 
The maximum length and thickness 
of each adrenal gland was measured in 
the longitudinal plane using electronic 
callipers. The maximum thickness was 
defined as the greatest dorsoventral 
dimension and was assessed as a single 
measurement made perpendicular to the 
long axis. The criterion that was assessed 
was thickness of the left adrenal gland 
less than 0.32 cm according to Wenger et 
al. (2010). 
The diagnosis of hypoadrenocorticism 
was established by the ACTH stimulation 
test. This test was performed in all 14 dogs 
by measuring basal cortisol concentration 
(prior to intravenous administration of 
0.25 mg synthetic ACTH) and stimulat-
ed cortisol concentrations (one hour after 
administration of ACTH) in veterinary 
accredited laboratories (either SYNLAB, 
München, Germany or LABOKLIN, Bad 
Kissingen, Germany) while the concen-
tration of endogenous ACTH (SYNLAB, 
München, Germany) was measured in 
one dog. The sample for measuring en-
dogenous ACTH concentration was taken 
into a precooled siliconized tube with an 
EDTA anticoagulant and after centrifu-
gation in precooled (4 °C) centrifuge, the 
plasma was immediately separated and 
frozen. Furthermore, the frozen plasma 
was handled on dry ice until analysis. The 
therapy protocols, and time required for 
stabilisation of each patient and their out-
comes were also investigated.
The treatment protocol during 
stabilization consisted of:
•	 Fluid therapy
 ₋ 20–40 mL/kg/h intravenous fluids 
(0.9% saline) during the first 
several hours, followed by 2–4 
mL/kg/h of fluids (0.9% saline 
until electrolyte balance achieved, 
then substituted with Plasmalyte 
or Ringer-lactate at the same rate)
•	 Glucocorticoids 
 ₋ intravenous dexamethasone (0.5–2 
mg/kg/day on the first day, then 
0.01–0.05 mg/kg/day until ACTH 
stimulation testing)
 ₋ intravenous prednisolone: 1–2 mg/
kg/day
•	 Mineralocorticoids:
 ₋ desoxycorticosterone pivalate 
(DOCP) – 2.2 mg/kg subcutane-
ously the first day
 ₋ fludrocortisone acetate perorally 
0.01– 0.03 mg/kg/day (divided into 
two doses)
•	 Treatment for hypoglycaemia:
 ₋ 0.5 g/kg 25% dextrose 
intravenously
After stabilization, prednisone was 
subscribed perorally (0.2–0.4 mg/kg/
day) in all 14 dogs. Mineralocorticoid 
supplementation was accomplished by 
peroral administration of fludrocortisone 
(0.01–0.03 mg/kg/day, divided into two 
doses) in 50% and by subcutaneous 
application of DOCP (2.2 mg/kg 
approximately every 25 days) in 43% of 
dogs while one dog (7%) with secondary 
hypoadrenocorticism did not receive 
mineralocorticoid supplementation.
Statistical analysis
Descriptive statistics was performed 
using the Statistica 8 for Windows 
program (StatSoft Inc.) with numerical 




The investigated population con-
sisted of 14 dogs with hypoadreno-
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corticism, representing 0.14% of the 
“first admission” patient popula-
tion. There were 5/14 (36%) males, 
(1/5 (20%) neutered) and 9/14 (64%) 
females (8/9 (88%) spayed). Among 
them, 4/14 (29%) were cross-breeds 
and 10/14 (71%) were pure breed dogs 
(three Standard Poodles and one rep-
resentative of each of the following 
breeds: Chihuahua, Miniature Poodle, 
Irish Setter, German Shepherd, White 
Swiss Shepherd, American Hairless 
Dog and St. Bernard) with overrep-
resentation of Standard Poodles: 3/10 
(30%) of pure breeds; 3/14 (21%) of ca-
Table 1. Frequency of symptoms and clinical 
signs in dogs with hypoadrenocorticism














Table 2. Vital signs in dogs with hypoadrenocorticism
Reference 
range Range Median ± 2sd
1 ↑ (%) ↓ (%) √ (%)
T (˚C) 38.0–39.2 35.6 - 39.4 37.9±2.6 14 64 22
P (b/min) 60–160 30 - 140 100±66.7 0 29 71
R (i/min) 10–40 8 - 38 25±18.1 0 7 93
T-body temperature, P-pulse: heart rate (beats per minute), R-respiratory rate (inspiration per minute)
↑- portion of dogs with increased values, ↓ - portion of dogs with decreased values.
√ - portion of dogs with normal values, 12sd-2 standard deviation.
Table 3. Haematology parameters in dogs with hypoadrenocorticism 







E [x 1012/L] 5.5 – 8.5 5.0 – 8.8 7.1±2.9
21 21 58Hb [g/L] 120 - 180 108 – 207 169.5±70.2
PCV [%] 37 – 55 31 – 61 47±20.4
L [x 109/L] 6 -17 5.1 – 24.8 8.7±10.6 7 7 86
PLT [x 109/L] 200 - 700 114 - 471 339.5±228.1 0 14 86
DBCC
Sg [%] 60 – 77 42 - 84 66.5±28.8 14 36 50
Nsg [%] - 1 1 - 4 3±3.1 14 - 86
Lym [%] 12 – 33 6 - 46 27±25.3 36 7 57
Mono [%] 3 – 10 1 – 10 4±6.4 0 21 79
Eo % 0-10 0-10 4±2.6 0 0 100
↑ - portion of dogs with increased values, ↓ - portion of dogs with decreased values, √ - portion of dogs with normal 
values, 
E-number of erythrocytes, Hb-haemoglobin concentration, PCV-packed cell volume, L-total leukocyte number, 
T-platelet number, DBCC-differential blood count, Sg-portion of segmented neutrophils, Nsg-portion of non-
segmented neutrophils, Lym-portion of lymphocytes, Mono-portion of monocytes, Eo-portion of eosinophils.
1Reference range: Centre for Clinical Pathology, Clinic for Internal Medicine, Faculty of Veterinary medicine, 
University of Zagreb, Croatia
 22sd-2 standard deviations. 
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nine hypoadrenocortism. Patient age 
(12–144 months; 36±79.6 months) and 
body weight (2.7–56 kg; 21.4±31.8 kg) 
varied markedly. The most common 
symptoms were of gastrointestinal or-
igin (Table 1). Hypothermia (Tables 1 
and 2) was present in 9/14 (64%) whilst 
bradycardia was noted in 4/14 (29%) of 
the investigated dogs (Table 2, Figs. 1 
and 2). Eight dogs (57%) were admit-
ted in hypovolemic decompensated 
shock (Figs. 1 and 2). The clinical ex-
amination data, and haematology and 
biochemistry results are shown in Ta-
bles 3 and 4. Twelve of 14 dogs (86%) 
were azotaemic. Among those, 7/12 
(58%) were diagnosed with prerenal 
and 5/12 (42%) with renal azotaemia.
Table 4. Biochemistry in dogs with hypoadrenocorticism
Parameter Reference range1 Range
Median ± 
2sd2 ↑ (%) ↓ (%) √ (%)
BUN [mmol/L] 3.3 - 8.3 4.3 - 51.3 29.5±29.9 86 0 14
Cre [µmol/L] 44 - 140 73 - 675 168±402.4 57 0 43
Chol [mmol/L] 3.7 - 7.1 1.6 - 8.3 4,4±4,5 14 21 65
BG [mmol/L] 3.6 - 6.5 1.7 – 5.9 4,8±2,8 0 21 79
AST [U/L] - 82 23 - 1195 83±794.8 29 - 71
ALT [U/L] - 88 28 - 185 47.0±89.6 14 - 86
AP [U/L] 30 - 156 10 - 241 26.5±109.3 7 14 79
TP [g/L] 55 - 75 51 - 76 68±16,8 7 7 86
Alb [g/L] 26 - 33 17 - 36 30±12.7 29 29 42
CRP [mg/L] 0 - 10.7 0 - 96.8 0±54.54 21 0 79
Ca [mmol/L] 2.1 - 3.1 2.1 - 2.9 2.35±0.62 0 0 100
Na [mmol/L] 140 – 155 117 - 154 128±21.7 0 71 29
K [mmol/L] 3.6 - 5.8 4 - 10.5 7.2±3.7 79 0 21
Na/K 27:1 - 40:1 12.3 - 38.5 18.1±14.3 0 86 14
BUN-blood urea nitrogen, Cre-creatinine, Chol-cholesterol, BG-blood glucose, AST-aspartate aminotransferase, ALT-
alanine aminotransferase, Ap-alkaline phosphatase, TP-total proteins, Alb-albumins, CRP-canine C-reactive protein, 
Ca-calcium, Na-sodium, 
K-potassium, Na/K-ratio, ↑-portion of dogs with increased values, ↓-portion of dogs with decreased 
values, √-portion of dogs with normal values. 
1Reference range: Centre for Clinical Pathology, Clinic for Internal Medicine, Faculty of Veterinary medicine, 
University of Zagreb, Croatia
22sd-2 standard deviations.
Figure 1. Addisonian crisis in a St. Bernard bitch 
with a diagnosis of hypoadrenocorticism
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Diagnostic imaging
Eight of 14 (57%) radiographic findings 
were unremarkable while microcardia 
and circulatory collapse were detected 
in 4/14 cases (29%) and gastroenteritis 
in 2/14 (14%). In 9/14 (64%) of dogs, 
“thinned and elongated” adrenals were 
detected by ultrasonography. All patients 
had a thickness of the left adrenal gland 
of less than 0.32 cm. 
Endocrinology testing
In all 14 dogs, ACTH stimulation 
testing showed extremely low cortisol 
concentrations, both basal and 
stimulated (<8.3 nmol/L). Concentration 
of endogenous ACTH was measured 
in 1/14 (7%) dog and was undetectably 
low (<1.10 pmol/L). On the basis of 
these results, a diagnosis of primary 
hypoadrenocorticism was established 
in 13/14 (93%) dogs and of secondary 
hypoadrenocorticism in 1/14 (7%). 
Twelve (92%) of 13 dogs with primary 
hypoadrenocorticism were diagnosed 
as typical, while 1/13 (8%) had atypical 
hypoadrenocorticism.
Symptom duration and the outcome
The timeframe between the onset of 
clinical signs and performance of ACTH 
stimulation test ranged from 2 – 2190 
(90±1195.5) days while the timeframe 
between objective presumption of 
hypoadrenocorticism and performing 
ACTH stimulation test was from 
0 – 11 (3.5±8.3) days. Upon initiation of 
treatment, the outcome was favourable in 
all 14 dogs.
Discussion
This study confirmed the literature 
data for canine hypoadrenocorticism 
regarding the wide age range (12 – 144 
months), predominance of females 
(64%) and increased prevalence of 
Standard Poodles (21%) (Peterson et 
al., 1996; Scott-Moncrieff, 2015). Since 
mineralocorticoid deficiency results 
in a disturbance of the Na/K ratio, 
dehydration and hypovolemic shock, 
whereas deficiency in glucocorticoids 
results in lethargy, weakness, shaking 
and numerous different gastrointestinal 
Figure 2. ECG tracing showing severe bradycardia (sinoventricular rhythm) due to severe hyperkalaemia 
in a St. Bernard bitch with a diagnosis of hypoadrenocorticism (leads I, II and III, 50 mm/s, 10 mm/mV), 
heart rate 46/min
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signs (i.e. vomiting, diarrhoea, abdominal 
pain, etc.), the clinical presentation 
of individual patient will depend on 
the combination of signs resulting 
from the prevailing deficiency at the 
moment. Recurrent gastrointestinal 
signs were noted in 100% of patients, 
among which vomiting was present in 
100%, diarrhoea in 64% and melena in 
7% of patients. Considering that these 
symptoms are common and unspecific, 
it is not unusual that the diagnosis 
of hypoadrenocorticism is often 
overlooked. Therefore, the success in 
reaching the diagnosis is primarily based 
on the clinician’s index of suspicion to 
initiate ACTH stimulation testing. In the 
case of recurring episodic gastrointestinal 
signs, hypoadrenocorticism should 
be included on the list of possible 
differentials, especially if patients are 
highly responsive to fluid treatment 
(Klein and Peterson, 2010b).
The results of this study showed 
that the majority of patients were in 
hypovolemic shock when admitted 
(57%), which was also supported 
by the presence of hypothermia 
(64%) and radiographically proven 
circulatory collapse and microcardia 
(29%). Bradycardia, although often 
associated with hypoadrenocorticism 
(due to hyperkalaemia often declared 
as the hallmark of Addison’s disease), 
is still relatively rare (29% in this 
study; 22-25% reported by Klein and 
Peterson (2010a)), especially compared 
to incidence of hyperkalaemia (79%). 
This is not surprising considering 
that not all hyperkaliaemic patients 
develop bradycardia, but only those 
with extremely high serum potassium 
concentrations. However, the presence 
of bradycardia in any collapsed 
dog should alert the clinician to put 
Addison’s disease at the top of the list 
of differentials, while the absence of 
bradycardia (71% in this study) does not 
exclude hypoadrenocorticism. 
As in previous studies (Thompson 
et al., 2007; Scott-Moncrieff, 2015), some 
similar abnormalities in haematology 
such as anaemia (21%), mature 
neutrophilia (14%), left-shift (14%) and 
lymphocytosis (36%) were also noted 
in this study, though due to their non-
specificity, most of these findings were of 
no diagnostic importance. However, the 
lack of stress leukogram in two severely 
sick hypovolemic dogs with no electrolyte 
abnormalities directed us to perform 
ACTH stimulation testing. Both of these 
patients were initially treated with only 
glucocorticoid supplementation, and 
electrolyte imbalance occurred later, 
so mineralocorticoid supplementation 
was subsequently added to the therapy 
protocol. 
The most commonly observed 
biochemistry discrepancies in canine 
hypoadrenocorticism included azotaemia 
(86%), hyperkalaemia (79%) and 
hyponatremia (79%), which can occur 
either independently or in combination 
(Kintzer and Peterson, 1997; Greco, 2007; 
Scott-Moncrieff, 2010; Scott-Moncrieff, 
2015). Azotaemia with or without 
increased creatinine concentration 
is the consequence of hypovolemia, 
hypotension and decreased renal 
perfusion, though it can also indicate 
kidney injury or even renal failure due 
to delayed treatment of hypovolemia 
(Scott-Moncrieff, 2015). In this study, 
58% of patients had pre-renal azotaemia 
as a consequence of hypovolemia, 
hypotension and shock (decreased renal 
perfusion). However, prolonged renal 
hypoperfusion due to delayed shock 
therapy will ultimately result in renal 
azotaemia, which was also noted in this 
study as the remaining 42% of azotaemic 
patients had urine specific gravity less 
than 1030. It is important to understand 
that renal azotaemia is not a synonym 
for renal failure, as some patients may 
have renal dysfunction without having 
structural renal disease. They may have 
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a functional problem and in patients 
with hypoadrenocorticism, this is most 
often due to hyponatremia. It is a well-
established fact that sodium is the osmotic 
fundament of plasma, thus the loss of 
sodium reduces total body water, which 
in turn reduces the glomerular filtration 
rate and therefore results in azotaemia. 
Moreover, low sodium impairs osmotic 
stimuli for antidiuretic hormone secretion 
and promotes urine dilution (Maddison, 
2008). In patients with Addison’s disease, 
aldosterone deficiency is the main cause 
of the inability of kidney to retain sodium 
and to excrete potassium and hydrogen 
ions, resulting in hyponatremia and 
hyperkalaemia, which in some cases 
is combined with metabolic acidosis 
(Kemppainen and Behrend, 1997; Scott-
Moncrieff, 2015). The Na/K ratio has been 
used for many years but its diagnostic 
value has proven controversial. Namely, 
the reference range of the physiological 
Na/K ratio varies from 27:1 to 40:1, and 
the previous recommendations for 
suspicion of canine hypoadrenocorticism 
was a ratio below 27:1. Different studies 
were conducted to test the Na/K ratio in 
dogs with various systemic conditions 
(<15-24:1 Roth and Tyler, 1999; <24:1 
Adler et al., 2007) and they found that 
different diseases may cause a lowering of 
the Na/K ratio, i.e. abdominal or thoracic 
effusions, sepsis, kidney diseases, 
cardiorespiratory diseases, parvovirus 
infection and trichuris invasion (Roth 
and Tyler, 1999; Nielsen et al., 2008). 
Nielsen et al. (2008) showed that only 
16.7% of cases of Na/K ratio <27:1 were 
caused by Addison’s disease, while the 
vast majority (83.3%) of Na/K ratios <27:1 
(previously proposed as a diagnostic for 
Addison’s disease) were caused by other 
diseases.
The vast majority of patients in 
the present study had a Na/K ratio 
below 27:1; however, since we did 
not investigate the Na/K ratio in other 
diseases, we cannot conclude about the 
share of patients with low Na/K ratios 
due to other causes. Roth and Tyler 
(1999) found that all dogs in their study 
with a Na/K ratio <15:1 had Addison’s 
disease, which can be considered as too 
strict a cut-off point when analysing 
results of this study. In other words, with 
such a low cut-off point, we would not 
have tested 10 of the 14 dogs in this study 
(with ACTH stimulation test). Therefore, 
the presumption that Addison’s disease 
is diagnosed only on the basis of 
electrolyte disturbance is misleading. 
Therefore, despite substantial evidence of 
the usefulness of electrolyte disturbances 
in presuming Addison’s disease, the 
evidence for a direct link between serum 
sodium and potassium in relation to a 
specific disease are very limited. Hence, 
despite the Na/K ratios previously 
recommended as a diagnostic for 
hypoadrenocorticism, the only objective 
diagnosis of canine hypoadrenocorticism 
can be established via ACTH-stimulation 
testing. It is important to emphasise that 
some dogs with Addison’s disease may 
have both normal potassium and sodium 
concentrations and therefore a normal 
ratio due to either secondary or early 
primary (atypical) hypoadrenocorticism. 
The golden standard for differentiating 
between primary and secondary 
hypoadrenocorticism is measurement of 
the endogenous ACTH concentration. 
There is no better way to deal with atypical 
hypoadrenocorticism than regular checks 
of electrolyte concentrations to detect the 
development of Na/K ratio disturbances, 
and to initiate mineralocorticoid 
supplementation as needed.
One of the features of canine 
hypoadrenocorticism is also 
hypoglycaemia due to the lack of 
glucocorticoids, which was present in up 
to 30% of dogs and in some cases can cause 
seizures (Levy, 1994; Lifton et al., 1996; 
Syme and Scott-Moncrieff, 1998). One of 
the pitfalls of canine Addison’s disease is 
that hypoglycaemia is more common in 
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toy breeds which are already predisposed 
to hypoglycaemia. This is in concordance 
with the results of this study, in which 
among 21% of hypoglycaemic patients 
the only one to developed seizures was a 
toy breed patient.
The number of dogs with 
hypocholesterolaemia observed in 
this study was significantly higher 
(21%) than in other studies (7%) (Scott-
Moncrieff, 2015). It is assumed that 
hypocholesterolaemia accompanied 
with hypoalbuminemia can be caused 
by acute ischemia of the gastrointestinal 
(GI) system (Peterson et al., 1996; Adler et 
al., 2007), and therefore the significantly 
higher portion of hypocholesterolaemic 
patients in this study can be explained 
by the fact that all dogs in this study 
were admitted with acute gastroenteritis 
(causing acute ischemia of the GI tract) 
after several previously treated GI 
episodes. This is also supported with a 
significantly higher portion of recurring 
GI signs in this study (100%) compared 
to similar studies (50%; Seth et al., 2011).
The duration of symptoms was ex-
tremely variable but still quite long 
(2 – 2190 days, mean 90±1195.5 days) 
supporting the premise that Addison’s 
disease is still too often unattended or 
even overlooked in Croatian veterinary 
practice. Of course, we cannot claim that 
all previous episodes of gastrointestinal 
(and other) signs were due to undiscov-
ered hypoadrenocorticism, though simi-
larly, we cannot be certain that this was 
not the case in some or all of the patients, 
particularly since the vast majority of 
patients were treated symptomatically 
for some time. Following treatment, all 
patients were doing better for a while, 
but never stopped relapsing and com-
ing back to the same or different veter-
inary practice until their admission to 
the emergency service of our clinic due 
to severe hypovolemic shock. The aim of 
this study was to emphasize the “tricky” 
nature of this disease, making diagnosis 
difficult in patients for which Addison’s 
disease was not included on the list of 
differentials. Moreover, the recurrent 
signs did not return in any patient after 
initialization of proper treatment (i.e. 
glucocorticoid and mineralocorticoid 
supplementation).
Accordingly, the golden rule in 
diagnosing canine hypoadrenocorticism 
should combine measurement 
of electrolyte concentration and 
performing ACTH stimulation test 
in any dog presented with recurring 
GI symptoms. Although not crucial, 
diagnostic imaging can also be a very 
helpful tool in the diagnostic workup of 
hypoadrenocorticism. As most dogs with 
hypoadrenocorticism have a measurable 
reduction in the size of the adrenal glands 
on ultrasound examination, they appear 
thinner than healthy adrenal glands for 
the dog of determined size and body 
weight. As they become thinner, to the 
ultra-sonographer they appear wormlike, 
explained by the words “thin and 
elongated” in contrary to their normal 
shape (peanut shaped left and arrow tip 
shaped right adrenal gland).
All patients were treated in line with 
the current therapy protocols (fluids, 
glucocorticoids, mineralocorticoids) 
and the outcome was favourable in all 
patients, which is in concordance to 
other studies. Discovery and usage of 
DOCP greatly facilitated, improved and 
simplified treatment protocols, since 
it is an injectable medication given on 
monthly basis (in comparison with 
fludrocortisone which should be given 
perorally twice per day). Moreover, 
Baumstark et al. (2014) demonstrated that 
DOCP suppresses plasma renin activity 
more effectively than fludrocortisone, 
suggesting that DOCP is more effective 
than fludrocortisone at replacing 
aldosterone in Addisonians. In this 
study, the dose of DOCP was 2.2 mg/kg 
as recommended, though a recent study 
recommended a starting dosage of 1.5 
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mg/kg of DOCP as effective in controlling 
clinical signs and serum electrolyte 
concentrations in the majority of dogs 
with hypoadrenocorticism (Sieber-
Ruckstuhl et al., 2018).
In conclusion, Addison’s disease can 
have numerous different presentations 
and the difficulty of diagnosis does not 
lie in performing complicated diagnos-
tics, but in considering it as a possibility. 
The combination of prolonged history 
(previous episodes of similar unspecific 
signs), clinical signs (especially hypo-
volemia and bradycardia), laboratory 
results (especially electrolyte distur-
bances and azotaemia) and diagnostic 
imaging (“thin and elongated” adrenal 
glands) should be sufficient in pursuing 
with the diagnostics of hypoadreno-
corticism. Although hypoadrenocorti-
cism is often described as a diagnostic 
challenge, it should actually be termed 
a “remembrance challenge” since once 
awoken, the likelihood of detection of 
hypoadrenocorticism with ACTH stim-
ulation test (as easy to perform as to in-
terpret) is in fact certain.
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Pod pojmom hipoadrenokorticizam 
podrazumijevamo smanjenu funkciju 
nadbubrežne žlijezde, a sama bolest je 
poznata i pod nazivom Addisonova bolest. 
Hipoadrenorticizam je bolest koja se u pasa 
rijetko javlja s učestalošću od oko 0,1 %. Zbog 
kombinacije nespecifičnih simptoma i njihova 
osciliranja predstavlja dijagnostički izazov 
te se smatra bolešću čija se u veterinarskoj 
medicini dijagnoza najčešće previdi. Postoji 
primarni i sekundarni oblik bolesti. Cilj je ovog 
istraživanja bio detaljno analizirati podatke 
pasa s Addisonovom bolešću zaprimljenih u 
Kliniku za unutarnje bolesti Veterinarskog 
fakulteta Sveučilišta u Zagrebu te ih usporediti 
s podatcima iz sličnih institucija u svijetu. 
Detaljno su pretraženi podatci arhive klinike, 
a analizirani su i statistički obrađeni klinički 
i laboratorijski parametri, vrijeme trajanja 
simptoma te terapijski protokoli i ishod u pasa s 
hipoadrenokorticizmom. Istraživanu skupinu 
činilo je 14 pasa s hipoadrenokorticizmom 
od kojih 36 % mužjaka i 64 % ženki. U svih 
pasa zabilježeni su recidivirajući simptomi 
od strane probavnog sustava, od kojih se u 
100 % slučajeva javljalo povraćanje, u 64 % 
proljev, a u 7 % melena. Klinički je u 57 % 
pasa uočen hipovolemični šok, u 64 % pasa 
hipotermija, a u 29 % bradikardija. Od 
laboratorijskih pretraga najčešća odstupanja 
bila su povećanje koncentracije ureje (86 %), 
kreatinina (57 %), hiperkalemija (79 %), 
hiponatremija (71 %), smanjeni Na/K 
omjer (86 %), hipoholesterolemija (21 %) te 
hipoglikemija (21 %). Trajanje simptoma do 
provedbe ACTH-stimulacijskog testa iznosilo 
je 2 - 2190 dana (prosječno 90±1195 dana), a 
nakon uvođenja adekvatne terapije ishod je u 
svih pasa bio povoljan.
Ključne	 riječi:	 Addisonova bolest, deficit 
mineralokortikoida, deficit glukokortikoida, 
nadbubrežna žlijezda, pas
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